GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Cyclically Adjusted FCF per Share

TSH Biopharm (ROCO:8432) Cyclically Adjusted FCF per Share : NT$2.00 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

TSH Biopharm's adjusted free cash flow per share for the three months ended in Mar. 2024 was NT$1.391. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$2.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, TSH Biopharm's average Cyclically Adjusted FCF Growth Rate was -10.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of TSH Biopharm was 0.80% per year. The lowest was 0.80% per year. And the median was 0.80% per year.

As of today (2024-06-13), TSH Biopharm's current stock price is NT$64.20. TSH Biopharm's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was NT$2.00. TSH Biopharm's Cyclically Adjusted Price-to-FCF of today is 32.10.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of TSH Biopharm was 44.23. The lowest was 18.61. And the median was 29.62.


TSH Biopharm Cyclically Adjusted FCF per Share Historical Data

The historical data trend for TSH Biopharm's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm Cyclically Adjusted FCF per Share Chart

TSH Biopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.66 1.32 1.95 1.70

TSH Biopharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.24 2.19 1.81 1.70 2.00

Competitive Comparison of TSH Biopharm's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TSH Biopharm's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where TSH Biopharm's Cyclically Adjusted Price-to-FCF falls into.



TSH Biopharm Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TSH Biopharm's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.391/131.7762*131.7762
=1.391

Current CPI (Mar. 2024) = 131.7762.

TSH Biopharm Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.524 100.560 1.997
201409 1.846 100.428 2.422
201412 -0.245 99.070 -0.326
201503 0.672 99.621 0.889
201506 0.848 100.684 1.110
201509 0.306 100.392 0.402
201512 0.099 99.792 0.131
201603 0.157 100.470 0.206
201606 1.149 101.688 1.489
201609 -0.118 101.861 -0.153
201612 -0.114 101.863 -0.147
201703 0.262 102.862 0.336
201706 0.971 103.349 1.238
201709 0.838 104.136 1.060
201712 -0.086 104.011 -0.109
201803 0.432 105.290 0.541
201806 0.656 106.317 0.813
201809 -0.006 106.507 -0.007
201812 0.386 105.998 0.480
201903 0.280 107.251 0.344
201906 0.526 108.070 0.641
201909 1.312 108.329 1.596
201912 0.100 108.420 0.122
202003 -0.721 108.902 -0.872
202006 0.475 108.767 0.575
202009 0.356 109.815 0.427
202012 0.125 109.897 0.150
202103 0.517 111.754 0.610
202106 0.590 114.631 0.678
202109 0.430 115.734 0.490
202112 0.259 117.630 0.290
202203 -0.219 121.301 -0.238
202206 0.823 125.017 0.867
202209 0.471 125.227 0.496
202212 -0.678 125.222 -0.713
202303 -0.140 127.348 -0.145
202306 0.713 128.729 0.730
202309 -0.280 129.860 -0.284
202312 0.450 129.419 0.458
202403 1.391 131.776 1.391

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


TSH Biopharm  (ROCO:8432) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

TSH Biopharm's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=64.20/2
=32.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of TSH Biopharm was 44.23. The lowest was 18.61. And the median was 29.62.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


TSH Biopharm Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


TSH Biopharm (ROCO:8432) Business Description

Traded in Other Exchanges
N/A
Address
No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically.

TSH Biopharm (ROCO:8432) Headlines

No Headlines